The largest database of trusted experimental protocols

Hd 351

Manufactured by Tanita
Sourced in United States, Japan

The Tanita HD-351 is a compact and portable body composition analyzer. It measures body weight, body fat percentage, and other body composition metrics. The device uses bioelectrical impedance analysis technology to provide these measurements.

Automatically generated - may contain errors

27 protocols using hd 351

1

Anthropometric and Blood Pressure Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Participant weight and height were measured in duplicate using a digital scale (Tanita HD 351: Tanita Corporation of America and portable stadiometer (SECA 213, Seca GmbH & Co), respectively. BMI (kg/m2) was calculated based on average measures of weight and height. Following a 10-minute seated rest period, blood pressure was measured three times, with a 3-minute rest period between measurements, using an Omron HEM-907XL automated blood pressure monitor (Omron HEM-907XL, Omron Healthcare). The last two measures were averaged for analyses.
+ Open protocol
+ Expand
2

Genetic and Health Profile Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Age and sex were self-reported. Weight and height were measured in duplicate to the nearest 0.1 kg and 0.1 cm using a digital weighing scale (Tanita HD 351; Tanita Corporation of America) and portable stadiometer (SECA 213, Seca GmbH & Co), averaged, and used to compute BMI. Abdominal circumference was measured in duplicate to the nearest 0.1 cm at the level of the umbilicus and averaged. CREBRF rs373863828 genotype data, generated via TaqMan real-time PCR (Applied Biosystems), came from the earlier 2010 GWAS study [16 (link)]. Based on current use of diabetes medication or Hemoglobin A1c (HbA1c) values, participants were categorized as having no diabetes (no diabetes medication and HbA1c <5.7%), pre-diabetes (no diabetes medication and HbA1c of 5.7–6.4%), or type 2 diabetes (diabetes medication and/or HbA1c>6.4%). Blood pressure (BP) was measured in triplicate and the second and third values averaged for analyses. Hypertension was defined as an average BP ≥140/90 mmHg, in line with local diagnostic criteria, or hypertension medication use. Asthma diagnoses were self-reported by participants. The Short Form-8 (SF-8) was used to assess perceived physical and mental health using the Physical Health Component Score and Mental Health Component Score summary measures. Both result in values of 0–100 with higher scores indicating better perceived health [20 ].
+ Open protocol
+ Expand
3

Anthropometric Measurements Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using standardised protocols, height was measured to the closest 0.1 cm using a portable stadiometer (Seca 214, Hamburg, Germany). Body weight was measured, with participants in light clothing, to the closest 0.1 kg using calibrated electronic weighing scales (Tanita HD-351, Tanita Corporation, Arlington Heights, IL, USA). Waist circumference was measured to the closest 0.1 cm at the end of a normal expiration and mid-point between the lower costal border and the iliac crest using a steel tape (W606PM, Lufkin, TX, USA). All measurements were taken in duplicate, and a third measure was taken if the first two measures differed by more than 1 percent. Body mass index (BMI) was calculated by dividing body weight in kilograms by the square of height in metres. (kg·m−2). Weight status was defined based on WHO BMI cut-offs: underweight (BMI < 18.5 kg·m−2), normal (BMI = 18.5–24.9 kg·m−2), overweight (BMI = 25.0–29.9 kg·m−2) and obese (BMI ≥ 30 kg·m−2).
+ Open protocol
+ Expand
4

Anthropometric and Cardiometabolic Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
To calculate BMI, height was measured to the nearest 0.1 cm using a portable SECA anthropometer (SECA 213, Seca GmbH & Co., Hamburg, Germany) and weight to the nearest 0.1 kg using a Tanita HD 351 digital scale (Tanita Corporation of America, IL). After a 10-minute seated rest period BP was measured three times, with 3-minute rest periods between measurements, using an Omron HEM907 XL digital monitor (Omron Healthcare, IL). The second and third measurements were averaged for analysis (removing the first to reduce risk of “white coat syndrome” elevations during initial measurement). HbA1c was measured with a random finger-prick blood sample (A1C Now, PTS Diagnostics, IN). Fasting Blood Glucose (FBG) (Bayer Contour, NJ) was measured in a small number of participants, where HbA1c kits were unavailable (based on supply shortages). Participant demographic characteristics (age, sex, and educational attainment) were self-reported.
+ Open protocol
+ Expand
5

Genetic and Health Profile Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Age and sex were self-reported. Weight and height were measured in duplicate to the nearest 0.1 kg and 0.1 cm using a digital weighing scale (Tanita HD 351; Tanita Corporation of America) and portable stadiometer (SECA 213, Seca GmbH & Co), averaged, and used to compute BMI. Abdominal circumference was measured in duplicate to the nearest 0.1 cm at the level of the umbilicus and averaged. CREBRF rs373863828 genotype data, generated via TaqMan real-time PCR (Applied Biosystems), came from the earlier 2010 GWAS study [16 (link)]. Based on current use of diabetes medication or Hemoglobin A1c (HbA1c) values, participants were categorized as having no diabetes (no diabetes medication and HbA1c <5.7%), pre-diabetes (no diabetes medication and HbA1c of 5.7–6.4%), or type 2 diabetes (diabetes medication and/or HbA1c>6.4%). Blood pressure (BP) was measured in triplicate and the second and third values averaged for analyses. Hypertension was defined as an average BP ≥140/90 mmHg, in line with local diagnostic criteria, or hypertension medication use. Asthma diagnoses were self-reported by participants. The Short Form-8 (SF-8) was used to assess perceived physical and mental health using the Physical Health Component Score and Mental Health Component Score summary measures. Both result in values of 0–100 with higher scores indicating better perceived health [20 ].
+ Open protocol
+ Expand
6

Comprehensive anthropometric and vascular assessments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Height was measured to the nearest 0.1 cm using a portable stadiometer (Seca 213, Hamburg, Germany). Weight was measured to the nearest 0.1 kg using a portable weight scale (Tanita HD-351, Arlington Heights, USA) with participants lightly clothed. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m). Systolic and diastolic blood pressure was measured using the SphygmoCor XCEL device that automates measurement using a brachial cuff via three one-minute cuff inflation cycles, and central blood pressure estimated by use of a proprietary general transfer function (AtCor Medical, Sydney). Bilateral carotid intima-media thickness was asssessed by high-resolution ultrasound from a single angle of convenience from both left and right carotid arteries in the PerioCardio study [15 ], and from up to 3 angles per carotid artery in the study involving Aboriginal Australians with kidney disease.
+ Open protocol
+ Expand
7

Anthropometric and Body Composition Measurements

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resting blood pressure was measured with an electronic sphygmomanometer (Omron HEM-71111-AU, Omron Healthcare, Kyoto, Japan). Participants were weighed with a calibrated scale (Tanita HD-351, Arlington Heights, IL, USA) without shoes and height was measured with a stadiometer (HoltainLtd., Crymych, UK). BMI was calculated using these data. Waist circumference was taken with a tape measure at the top of the iliac crest. All measurements were taken twice and the average was reported. Dual-energy X-ray absorptiometry (DXA) was performed for total fat mass and central adiposity (android % fat) (Prodigy, GE-Lunar, Madison, WI, USA).
+ Open protocol
+ Expand
8

Anthropometric Measurements and Body Composition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Height, body mass and skinfolds were measured using precise tools, including electronic scale to the nearest 0.1 kg (HD-351; Tanita, Arlington Heights, Illinois, USA), portable stadiometer to the nearest 0.001 m (SECA Leicester, United Kingdom) and caliper to the nearest 0.5 mm (Harpenden, West Sussex, UK).
Body mass index was calculated by the ratio of body mass (kg) to square height (m²), and body fat (BF) was estimated from the sum of 4 skinfolds (Triceps, Biceps, Subscapular Suprailiac) using Durnin and Womersley (1974[8 (link)]) formula;
BF % = (4.95 / D) - 4.50where BF is the estimated body fat percentage and D is the density of the body, which is calculated using the sum of the four skinfolds (in millimeters) according to the equation:
D = 1.0994921 - (0.0009929 x sum of skinfolds) + (0.0000023 x sum of skinfolds²) - (0.0001392 x age)
+ Open protocol
+ Expand
9

Anthropometric Measurements Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Body height and body mass were measured using a stadiometer (SECA, Leicester, UK) and an electronic scale (HD-351, Tanita, Illinois, USA), respectively. Percent of body fat was calculated from the sum of 10 skinfolds using a skinfold caliper (Harpenden, West Sussex, UK). Calculations were based on the formula proposed by Parizkova (1978) . Three trials were given for each anthropometric measurement in rotational order, and the average value was recorded.
+ Open protocol
+ Expand
10

Comprehensive Body Composition Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
A body composition monitor (HD-351, Tanita, Arlington Heights, IL, USA) measured the player's body mass. The height of the participants was determined utilizing a stadiometer (Seca 217, Germany). The error of the instrument for body weight and height was approximately 0.1 kg and 0.1 cm, respectively. Also, the fat percentage (%) of players was estimated based on the skinfold thickness measurement method using a skinfold caliper (Harpenden, United Kingdom). The following sites were assessed: biceps, triceps, suprailiac, subscapular, supraspinal, thigh, abdominal, and calf. The estimated BF% was then calculated for each player, using Reilly's formula [36 (link)]. A researcher with ISAK 2 certification performed the assessments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!